MIRA INFORM REPORT

 

 

Report Date :

24.12.2014

 

IDENTIFICATION DETAILS

 

Name :

SIGNA S A DE C.V.

 

 

Registered Office :

Av Industrial Toluca, Toluca Estado De Mexico CP 50071

 

 

Country :

Mexico

 

 

Date of Incorporation :

07.12.1961

 

 

Legal Form :

Sociedad Anonima de Capital Variable

 

 

Line of Business :

Manufacture and Sale of Chemicals and Biological Reagents that are used as raw Materials in the pharmaceutical Industry.

 

 

No. of Employee :

403

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

Mexico

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

MEXICO ECONOMIC OVERVIEW

 

Mexico's $1.3 trillion economy has become increasingly oriented toward manufacturing in the 20 years since the North American Free Trade Agreement (NAFTA) entered into force. Per capita income is roughly one-third that of the US; income distribution remains highly unequal. Mexico has become the United States' second-largest export market and third-largest source of imports. In 2013, two-way merchandise trade reached nearly $507 billion. Mexico has free trade agreements with over 50 countries including Guatemala, Honduras, El Salvador, the European Free Trade Area, and Japan - putting more than 90% of trade under free trade agreements. In 2012 Mexico formally joined the Trans-Pacific Partnership negotiations and formed the Pacific Alliance with Peru, Colombia and Chile. Mexico's current government, led by President Enrique PENA NIETO, emphasized economic reforms during its first year in office, passing education, energy, financial, fiscal and telecommunications reform legislation. The three-party "Pact for Mexico" reform agenda aims to improve competitiveness and economic growth across the Mexican economy.

 

Source : CIA

 

 

 

STATUTORY INFORMATION

 

Order:

SIGNA S A DE C.V.

Address in the order:

Av Industrial Toluca, Toluca Estado De Mexico CP 50071 , Mexico

Legal Name:

Signa, S.A de C.V.

Trade Name:

Signa

RFC:

 SIG611207ST9

Date Created:

1961

Date Incorporated:

December 7, 1961

Legal Address:

Avenida Industria Automotriz 301, 50020 Toluca de Lerdo, MEX, México

Operative Address:

Avenida Industria Automotriz 301, 50020 Toluca de Lerdo, MEX, México

Telephone:

52 (722) 226 1100

Fax:

52 (722) 226 1100

Legal Form:

Sociedad Anonima de Capital Variable

Email:

ovivanco@signa.mx

Registered in:

Mexico

Website:

www.signa.com.mx (undermaintenance)

Manager:

Jose Eloy Herranz

Staff:

403

Activity:

Chemical Manufacturing Industry

 

 

BANKS

 

 

The company does not make its banking data public.

 

 

 

HISTORY

 

 

It was established in 1961 while the manufacturing of active pharmaceutical ingredients (APIs) started in 1965. Although the initial focus was to supply the Mexican market, it reorganised in 1994/1995 to meet the requirements of the highly regulated market.

 

 

PRINCIPAL ACTIVITY

It is focused on the development, manufacture and sale of chemicals and biological reagents that are used as raw materials in the pharmaceutical industry.

Products/Services description:

The company stated that 33 products (SMF states over 40 products) were currently manufactured in its multipurpose facilities and supplied to the domestic, American, Canadian, Japanese, European and South American markets. These were typically API intermediates and APIs for use in OSD formulations. None included antibiotics (including penicillin, cephalosporins), agrochemicals or cytotoxic materials although it was stated that cytotoxic products may be produced on campaign basis with appropriate control measures.

Brands:

SIGNA

Sales are:

Wholesale

Clients:

Pharmacies, distributors - FARMACEUTICA PYASA
Paraguay

Suppliers:

Gp Racing Srl Italy


Sodikart Portugal


CHEMTURA ORGANOMETALLICS GMBH Germany

Operations area:

National

The company imports from

Europe

The company exports to

Paraguay

The subject employs

The site employed 403 staff (10 PhD, 35 Masters, 116 Bachelor and 100

Technicians) distributed as:

 

  • General Management 2
  • Technical Direction (R&D) 38
  • Risk Engineering and Management 12
  • Engineering Direction 51
  • Logistics Direction 25
  • Production Direction 193
  • Quality Direction 59
  • Comptrollership 9
  • Human Resources Management 10
  • Information Technology Mngt 4

Payments:

Regular

 

 

 

LOCATION

 

Headquarters :

Avenida Industria Automotriz 301, 50020 Toluca de Lerdo, MEX, México

Comments:

According to the SMF and company presentation at the opening meeting, the site is
located on 10,112 acres of land with the following facilities:
4 production plants (Plant A, C, D & E) with total reaction capacity of 93,645 gallons

2 distillation column systems

21 finishing rooms, including 10 FP rooms with controlled environments
3 warehouses: raw materials, intermediates and Finished product

Solvent storage tank farm

Analytical operations/quality control laboratories

R&D process and analytical laboratories

Utilities like process water, cooling water, compressed air, steam, chilled water, nitrogen

 

Branches:

The company does not have branches

 

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

 

Listed at the stock exchange:

NO

Capital:

NA

Shareholders %:

This is a private company. It is a subsidiary of:

Signa Chemistry Inc
530 East 76th Street #9e,
New York, NY 10021
USA

Management:

Mr. Oscar Vivanco, President & General Manager
Mr. Pedro Gorgonio, Director of Quality

Related Companies:

No subsidiary companies

 

 

 

FINANCIAL INFORMATION

 

 

This is a private company which does not make its financial statements public.

 

 

Signa Chemistry Inc (parent company)

USD 2013

Revenue

8 400 000

 

 

 

LEGAL FILINGS

 

 

There are no legal/criminal connected to the subject

 

 

RISKMA REVIEW

 

 

 

Riskma Review:

2

RISK:

Low

 

 

Requested Credit Amount

Maximum

Maximum Credit Provided

USD 50 000

 

 

 

SUMMARY

 

 

It is focused on the development, manufacture and sale of chemicals and biological PRODUCTS.


The company imports mainly from Europe and focus on national market.


It has a medium-large sized structure and complies with all health and safety requirements.


There are no negtaive.

 

 

 

RISK INFORMATION

 

 

 

DEBTS

Controlled

PAYMENTS

Unknown

CASH FLOW

Normal

SUGGESTED CREDIT LINE

USD 50 000

STATUS

ACTIVE

 

 

 

ENTERVIEW

 

NAME

Cinthia

POSITION

Administrative

COMMENTS

She confirmed address, branch and parent company. She refused to provide more data.

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.45

UK Pound

1

Rs.98.88

Euro

1

Rs.77.62

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

ANK

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.